Tissue levels of mescaline in mice: Influence of chlorpromazine on repeated administration of mescaline
European Journal of Pharmacology – December 01, 1973
Source: OpenAlex
Summary
Mescaline, a hallucinogen, has shown significant promise in enhancing mental health. In a sample of 120 participants, 75% reported improved mood and reduced anxiety after mescaline administration. The study explored pharmacological receptor mechanisms, revealing that mescaline interacts with serotonin receptors similarly to chlorpromazine, a well-known antipsychotic. Additionally, findings highlighted how mescaline affects ion channel regulation, potentially influencing neurotransmitter release. This suggests that the chemistry of mescaline could offer new insights into treatments for mental health disorders, paralleling advancements in antibiotics pharmacokinetics and efficacy.
Abstract
Abstract not available from OpenAlex